Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,819
archived clinical trials in
Brain Cancer

Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Methodist Estabrook Cancer Center
mi
from
Omaha, NE
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Methodist Estabrook Cancer Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
State University of New York Upstate Medical University
mi
from
New York, NY
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
State University of New York Upstate Medical University
mi
from
New York, NY
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Highland Hospital
mi
from
Rochester, NY
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Highland Hospital
mi
from
Rochester, NY
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
University of Rochester, James P. Wilmot Cancer Center
mi
from
Rochester, NY
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
University of Rochester, James P. Wilmot Cancer Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Carolinas Medical Center
mi
from
Charlotte, NC
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Akron City Hospital Summa Health System
mi
from
Akron, OH
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Akron City Hospital Summa Health System
mi
from
Akron, OH
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Summa Barberton Hospital
mi
from
Barberton, OH
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Summa Barberton Hospital
mi
from
Barberton, OH
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
MetroHealth Med Ctr
mi
from
Cleveland, OH
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
MetroHealth Med Ctr
mi
from
Cleveland, OH
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Western Reserve University
mi
from
Cleveland, OH
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Western Reserve University
mi
from
Cleveland, OH
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Ohio State University Medical Center
mi
from
Columbus, OH
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Southwest General Health Center Ireland Cancer Center
mi
from
Middleburg Heights, OH
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Southwest General Health Center Ireland Cancer Center
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Cancer Care Center, Incorporated
mi
from
Salem, OH
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Cancer Care Center, Incorporated
mi
from
Salem, OH
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
UHHS Westlake Medical Center
mi
from
Westlake, OH
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
UHHS Westlake Medical Center
mi
from
Westlake, OH
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Cancer Treatment Center
mi
from
Wooster, OH
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Cancer Treatment Center
mi
from
Wooster, OH
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Abington Memorial Hospital
mi
from
Abington, PA
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Abington Memorial Hospital
mi
from
Abington, PA
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Lehigh Valley Hospital
mi
from
Allentown, PA
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Lehigh Valley Hospital
mi
from
Allentown, PA
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
UPMC - Heritage Valley Health System - The Medical Center
mi
from
Beaver, PA
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
UPMC - Heritage Valley Health System - The Medical Center
mi
from
Beaver, PA
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Penn State M.S. Hershey Med Ctr
mi
from
Hershey, PA
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Penn State M.S. Hershey Med Ctr
mi
from
Hershey, PA
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Thomas Jefferson University Hospital
mi
from
Philadelphia, PA
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Thomas Jefferson University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Reading Hospital & Medical Center
mi
from
West Reading, PA
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Reading Hospital & Medical Center
mi
from
West Reading, PA
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Medical University of South Carolina
mi
from
Charleston, SC
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Cancer Centers of the Carolinas - Eastside
mi
from
Greenville, SC
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Cancer Centers of the Carolinas - Eastside
mi
from
Greenville, SC
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Cancer Centers of the Carolinas - Faris Road
mi
from
Greenville, SC
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Cancer Centers of the Carolinas - Faris Road
mi
from
Greenville, SC
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Cancer Centers of the Carolinas - Greer Radiation Oncology
mi
from
Greer, SC
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Cancer Centers of the Carolinas - Greer Radiation Oncology
mi
from
Greer, SC
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Cancer Centers of the Carolinas - Seneca
mi
from
Seneca, SC
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Cancer Centers of the Carolinas - Seneca
mi
from
Seneca, SC
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Rapid City Regional Hospital
mi
from
Rapid City, SD
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
University of Texas Medical Branch
mi
from
Galveston, TX
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
University of Texas Medical Branch
mi
from
Galveston, TX
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
M.D. Anderson Cancer Center
mi
from
Houston, TX
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Methodist Hospital
mi
from
Houston, TX
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Intermountain Medical Center
mi
from
Murray, UT
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Intermountain Medical Center
mi
from
Murray, UT
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Utah Valley Regional Medical Center
mi
from
Provo, UT
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Utah Valley Regional Medical Center
mi
from
Provo, UT
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Dixie Medical Center Regional Cancer Center
mi
from
Saint George, UT
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Dixie Medical Center Regional Cancer Center
mi
from
Saint George, UT
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
LDS Hospital
mi
from
Salt Lake City, UT
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
LDS Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
University of Utah, Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
University of Utah, Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Virginia Commonwealth University
mi
from
Richmond, VA
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Swedish Cancer Institute
mi
from
Seattle, WA
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Swedish Cancer Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Virginia Mason CCOP
mi
from
Seattle, WA
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Virginia Mason CCOP
mi
from
Seattle, WA
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Saint Mary's Hospital
mi
from
Green Bay, WI
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Saint Mary's Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Saint Vincent Hospital
mi
from
Green Bay, WI
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Saint Vincent Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Gundersen Lutheran
mi
from
La Crosse, WI
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Gundersen Lutheran
mi
from
La Crosse, WI
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
University of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
University of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Froedtert and the Medical College of Wisconsin
mi
from
Milwaukee, WI
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Froedtert and the Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Waukesha Memorial Hospital
mi
from
Waukesha, WI
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Waukesha Memorial Hospital
mi
from
Waukesha, WI
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Royal North Shore Hospital
mi
from
St. Leonards,
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Royal North Shore Hospital
mi
from
St. Leonards,
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
St John's Mercy Medical Center
mi
from
Saint Louis, MO
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
St John's Mercy Medical Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
UHHS-Chagrin Highlands Medical Center
mi
from
Orange, OH
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
UHHS-Chagrin Highlands Medical Center
mi
from
Orange, OH
Click here to add this to my saved trials
A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma
Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma
Status: Enrolling
Updated:  7/31/2017
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma
Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma
Status: Enrolling
Updated: 7/31/2017
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials